rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Sotera Health Company

SHC · Nasdaq

Health CareProviders & FacilitiesLeading

SHC stood above a rising 150-day average in 34 of the last 52 weekly readings, including each of the last 16 weeks. It is 5.7% above that average now. Providers & Facilities: 45% of its 53 stocks in an uptrend (−6 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
16 in a row
Industry in uptrend
45% -6 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$4.0B
Officials’ trades on record
0
Institutions holding
292 (+18)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 34 of 52 weeks.

17 Apr – 16 Oct
26%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1.5B$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months21
Buyers · sellers0 · 13
WhoDidSharesTraded
Michael B. Petras, Jr.Executive Chairmansold294,515at $18.5017 Aug 2026filed 19 Aug 2026
Michael B. Petras, Jr.Executive Chairmansold850,000at $18.5017 Aug 2026filed 19 Aug 2026
Michael P. RutzPresident of Sterigenicssold150,000at $18.847 Aug 2026filed 11 Aug 2026
Gtcr Investment Xi LlcDirector, 10% ownersold12,735,301at $15.1713 May 2026filed 15 May 2026
Warburg Pincus & Co.Director, 10% ownersold19,102,952at $15.1713 May 2026filed 15 May 2026
Warburg Pincus & Co.Director, 10% ownersold19,102,952at $15.1713 May 2026filed 15 May 2026
Gtcr Investment Xi LlcDirector, 10% ownersold10,000,000at $15.276 Mar 2026filed 10 Mar 2026
Warburg Pincus & Co.Director, 10% ownersold15,000,000at $15.276 Mar 2026filed 10 Mar 2026
Warburg Pincus & Co.Director, 10% ownersold15,000,000at $15.276 Mar 2026filed 10 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders292+18 on the quarter
New · exited58 · 39
Reported value$5.0B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Sessa Capital IM, L.P.added · filed 14 Aug 202627,050,000$480.1M+4,000,000+17.4%
Darsana Capital Partners LPadded · filed 14 Aug 202627,000,000$479.3M+1,000,000+3.8%
BlackRock, Inc.added · filed 7 Aug 202624,148,424$428.6M+3,298,845+15.8%
Sculptor Capital LPadded · filed 14 Aug 202624,000,000$426.0M+2,282,272+10.5%
Sachem Head Capital Management LPadded · filed 14 Aug 202615,560,000$276.2M+3,915,000+33.6%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202612,170,699$216.0M+1,435,693+13.4%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 202611,946,341$212.0M+1,337,624+12.6%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 202610,734,313$186.4M+4,013,550+59.7%
Jupiter Topco LLCnew · filed 14 Aug 20268,402,106$149.1M+8,402,106
STATE STREET CORPadded · filed 7 Aug 20268,324,321$147.8M+1,302,695+18.6%
31 Mar 2023 – 30 Jun 2026
148218287Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Michael B. Petras Jr. Company insiderExecutive Chairman · last 17 Aug 20260 · 4
Michael P. Rutz Company insiderPresident of Sterigenics · last 7 Aug 20260 · 4
Jonathan M. Lyons Company insiderSr. Vice President, CFO · last 5 Aug 20260 · 0
Alton Shader Company insiderChief Executive Officer · last 26 May 20260 · 0
Ann R. Klee Company insiderDirector · last 22 May 20260 · 1
Christopher Simon Company insiderDirector · last 22 May 20260 · 0
David E. Wheadon Company insiderDirector · last 22 May 20260 · 0
James Neary Company insiderDirector · last 22 May 20260 · 0
Karen Flynn Company insiderDirector · last 22 May 20260 · 0
Kenneth D. Krause Company insiderDirector · last 22 May 20260 · 0
Richard G. Kyle Company insiderDirector · last 22 May 20260 · 0
Ruoxi Chen Company insiderDirector · last 22 May 20260 · 0

Same industry

PACS PACS GroupLeading+18%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202555.5%
Free cash flow marginFY 2025 · to 31 Dec 202512.8%
Cash conversionFY 2025 · to 31 Dec 2025368%
Debt to equityFY 2025 · to 31 Dec 20253.56×
Share count trendFY 2025 · to 17 Feb 2026-0.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$344.6M
Free cash flowFY 2025 · to 31 Dec 2025$149.2M

Analyst forecasts

No analyst forecasts yet.